hi mate, I can imagine that TGA will add five treatments per month to the sales tally early on. It appears the Adelaide Hospital is well established with using Oncosil as part of the research.
my personal opinion is any treatments starting in Germany will have a more profound effect on a re-rate.
but if you take it altogether, the things that are coming in the next six months, and the reduction of red tape, we should be sittieng on $200m market cap mid year everything goes by plan. - I will update my chart accordingly, and I will also dig out the exact Quarterly’s from TLX to compare with us. - I absolutely love this comparison, it has really helped me to understand our company in these increased revenue stages, when you compare with a company like Telix, even though they are somehow different.
- Forums
- ASX - By Stock
- OSL
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
OSL
oncosil medical ltd
Add to My Watchlist
2.43%
!
$1.01

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-8
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.01 |
Change
-0.025(2.43%) |
Mkt cap ! $14.29M |
Open | High | Low | Value | Volume |
$1.04 | $1.05 | $1.00 | $41.05K | 40.86K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 500 | $1.01 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.05 | 1249 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 17640 | 1.000 |
1 | 1000 | 0.990 |
1 | 2875 | 0.980 |
2 | 6000 | 0.970 |
1 | 1000 | 0.960 |
Price($) | Vol. | No. |
---|---|---|
1.045 | 1249 | 1 |
1.050 | 25048 | 2 |
1.075 | 1879 | 1 |
1.090 | 375 | 1 |
1.180 | 2500 | 1 |
Last trade - 15.47pm 20/06/2025 (20 minute delay) ? |
Featured News
OSL (ASX) Chart |